Company intelligence / Profile preview

FBM Regenerative Biology and Medicine

Frankfurt am Main, Hesse, Germany

Ownership: Private
Development stage: Other

Overview

FBM Regenerative Biology and Medicine is a biotechnology company based in Germany that focuses on the development of innovative therapies for tissue regeneration and wound healing. The company leverages its expertise in regenerative biology to identify and develop bioactive compounds that stimulate the body's innate repair mechanisms. Their research primarily targets chronic wounds and skin conditions where current treatments are insufficient. By focusing on the molecular pathways of regeneration, FBM aims to provide next-generation solutions for complex tissue repair challenges.

Therapeutic areas: Dermatology
Modalities: Small moleculePeptidesBiologic
Industry: Biotech

Beyond the preview

Go deeper on FBM Regenerative Biology and Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FBM Regenerative Biology and Medicine.

Explore the full profile